Part 1/8:
President Trump Announces Historic Move to Lower Drug Prices in the U.S.
President Donald Trump revealed a major policy shift aimed at drastically reducing prescription drug costs for Americans. In a televised announcement from the Oval Office, he committed that all new medications introduced by Pfizer to the U.S. market would be sold at the "most favored nation" (MFN) pricing—essentially the lowest price paid by any other country. This move aligns the United States' drug prices with those paid by nations that have historically negotiated much lower costs over the years.